Welcoming Rick Clemon to the Advisory Board

We are excited to announce that Rick Clemon has joined our Advisory Board!

Rick is a CFO with 30 years of experience spanning diverse sectors, including development and clinical-stage life science and medical device companies advancing research and development across pharmaceuticals, biologics, therapies, and assistive technologies focused on cancers, retinal disease, and kidney disease. Rick’s wisdom, enthusiasm, and passion for our mission will surely be a tremendous asset as EMBioSys moves towards clinical trials in humans.